Advanced Solution for Targeted Next Generation Sequencing (NGS) of Circulating Cell-Free Tumor DNA. ctDNA (Circulating Tumor DNA) consist of only a small fraction of cfDNA (Cell Free DNA). ctDNA mutations [...]
Low Chances of Rejection. Higher Matching Ability. Easier to Reprogram to Act Like Embryonic Stem Cells - Increasing Their Regenerative Capabilities. Stem cells have the potential for alleviating suffering [...]
Cell-Based Therapies to Treat Cancer Personalizing Treatments of Cancer as Stem-Cell Disease. Stem Cells offer New Potentials for Treating Diseases. Stem cells give rise to the tissues of all organs. [...]
Quantity and Quality of DNA are Similar to Blood Methods! Ayass BioScience, LLC now accepts mouthwash as a collection method for genomic DNA for our Pharmacogenetic Testing. This method is [...]
Detection Of Cancer at Early Stages! MUTATION DETECTION AT LOWER ALLELIC FRIEQUENCY! At Ayass BioScience we use an ultrasensitive method for detecting circulating tumor DNA. We can detect cancer with [...]
SCREENING AND EARLY CANCER DETECTION • REAL TIME MONITORING OF CANCER THERAPY Dying cancer cells shed very small amount of DNA into blood. Gene-sequencing machines decode millions of short fragments [...]
The Mitochondrial genome is extremely small when compared to the nuclear genome, and mitochondrial DNA (mtDNA) mutations are complex and difficult to trace, but they play an important role in [...]
Mass spectrometry-based proteomics are used to identify biomarkers in Alzheimer's Disease (AD) and to establish how these biomarkers change in the brain during disease progression. The study of peptides, proteomics [...]
Cytochrome P450 (CYP450) tests help determine how your body processes (metabolizes) or responds to medications. We look for variations in cytochrome P450 genes that can affect the breakdown of medications. Depending [...]
The Proteomics studies that corroborate Metabolomics findings are the next generation of laboratory testing using the Mass Spectrometry, a key technology for targeted protein and metabolite identification and quantification. This [...]
At Ayass BioScience, we use high-throughput Next Generation Sequencing technology to sequence cancer patients' solid tumor DNA (Breast cancer, Lung cancer, Colorectal cancer, Prostate cancer, Cervical cancer). Targeted sequencing of tumor DNA across our [...]
We inherit DNA from our parents - but it only part of equation. Epigenetics is alteration in gene expression rather then the genetic code that affects genetics. DNA methylation, histone [...]
